These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20588103)

  • 1. Role of HIV-1 Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection.
    Li JC; Yim HC; Lau AS
    AIDS; 2010 Jul; 24(11):1609-23. PubMed ID: 20588103
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection.
    Yim HC; Li JC; Lau JS; Lau AS
    AIDS; 2009 Jul; 23(12):1473-84. PubMed ID: 19622906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu.
    Dezube BJ
    Semin Oncol; 2000 Aug; 27(4):420-3. PubMed ID: 10950368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
    Fanales-Belasio E; Moretti S; Fiorelli V; Tripiciano A; Pavone Cossut MR; Scoglio A; Collacchi B; Nappi F; Macchia I; Bellino S; Francavilla V; Caputo A; Barillari G; Magnani M; Laguardia ME; Cafaro A; Titti F; Monini P; Ensoli F; Ensoli B
    J Immunol; 2009 Mar; 182(5):2888-97. PubMed ID: 19234184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
    Gupta S; Mitra D
    Indian J Biochem Biophys; 2007 Oct; 44(5):269-75. PubMed ID: 18341200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting.
    Goldstein G; Chicca JJ
    Vaccine; 2010 Jan; 28(4):1008-14. PubMed ID: 19931501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functions of Tat: the versatile protein of human immunodeficiency virus type 1.
    Romani B; Engelbrecht S; Glashoff RH
    J Gen Virol; 2010 Jan; 91(Pt 1):1-12. PubMed ID: 19812265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tat protein from HIV-1 binds to Mycobacterium avium via a bacterial integrin. Effects on extracellular and intracellular growth.
    Denis M
    J Immunol; 1994 Sep; 153(5):2072-81. PubMed ID: 8051412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunologic restoration in patients with AIDS. Requiem for prophylaxis].
    Peña JM; Miró JM
    Med Clin (Barc); 1999 Oct; 113(10):375-8. PubMed ID: 10562941
    [No Abstract]   [Full Text] [Related]  

  • 10. The ability of chloroquine to prevent tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity.
    Rayne F; Vendeville A; Bonhoure A; Beaumelle B
    J Virol; 2004 Nov; 78(21):12054-7. PubMed ID: 15479845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of opportunistic infections on the frequency of leukocyte subpopulations from type-1 human immunodeficiency virus infected individuals].
    Ramírez Z; Cataño JC; Román A; Rugeles MT; Montoya CJ
    Biomedica; 2008 Mar; 28(1):64-77. PubMed ID: 18645662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload.
    Hui B; Li J; Geng MY
    J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.
    Eldeen MB; Deshmane SL; Simbiri K; Khalili K; Amini S; Sawaya BE
    J Neuroimmunol; 2006 Jul; 176(1-2):174-80. PubMed ID: 16750572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus and acquired immunodeficiency syndrome: an update.
    Schnittman SM; Fauci AS
    Adv Intern Med; 1994; 39():305-55. PubMed ID: 8140958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis.
    Barillari G; Buonaguro L; Fiorelli V; Hoffman J; Michaels F; Gallo RC; Ensoli B
    J Immunol; 1992 Dec; 149(11):3727-34. PubMed ID: 1431144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein.
    Ensoli B; Fiorelli V; Ensoli F; Lazzarin A; Visintini R; Narciso P; Di Carlo A; Monini P; Magnani M; Garaci E
    AIDS; 2008 Oct; 22(16):2207-9. PubMed ID: 18832884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-macrophage interactions at the cellular and molecular level.
    Khati M; James W; Gordon S
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):367-78. PubMed ID: 11798135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.
    Zagury JF; Sill A; Blattner W; Lachgar A; Le Buanec H; Richardson M; Rappaport J; Hendel H; Bizzini B; Gringeri A; Carcagno M; Criscuolo M; Burny A; Gallo RC; Zagury D
    J Hum Virol; 1998; 1(4):282-92. PubMed ID: 10195253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.